First Trust Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

First Trust Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.7M	Buy	554,584 +15,508	+3%	+$247K	0.01%	1226
2025 Q4	$8.75M	Sell	539,076 -4,061	-0.7%	-$66.3K	0.01%	1158
2025 Q3	$8.13M	Sell	543,137 -198,169	-27%	-$2.41M	0.01%	1162
2025 Q2	$8.64M	Buy	741,306 +726,184	+4,802%	+$6.6M	0.01%	1136
2025 Q1	$112K	Sell	15,122 -1,335	-8%	-$10.3K	﹤0.01%	2504
2024 Q4	$98.7K	Buy	+16,457	New	+$90.7K	﹤0.01%	2528
2023 Q3	–	Sell	-125,630	Closed	-$843K	–	2344
2023 Q2	$843K	Buy	+125,630	New	+$934K	﹤0.01%	2028
2021 Q2	–	Sell	-326,635	Closed	-$13.2M	–	2470
2021 Q1	$13.2M	Sell	326,635 -144,731	-31%	-$7.83M	0.02%	852
2020 Q4	$27.9M	Sell	471,366 -78,356	-14%	-$4.04M	0.04%	534
2020 Q3	$26.7M	Buy	549,722 +493,526	+878%	+$20.7M	0.04%	463
2020 Q2	$2.72M	Buy	+56,196	New	+$2.05M	﹤0.01%	1227

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First Trust Advisors's ADPT Position: Q1 2026 in Review

First Trust Advisors increased its Adaptive Biotechnologies (ADPT) stake by 2.9% in Q1 2026, buying an estimated $247K and bringing the position to 554,584 shares worth $7.7M. The position accounts for 0.01% of the portfolio, ranked #1226.

First Trust Advisors first reported a position in ADPT in Q2 2020 and has held it in 11 quarters since. The position peaked at $27.9M in Q4 2020. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

First Trust Advisors held 554,584 shares of Adaptive Biotechnologies worth $7.7M as of Q1 2026.
First Trust Advisors bought 15,508 Adaptive Biotechnologies shares in Q1 2026, an estimated $247K.
Adaptive Biotechnologies made up 0.01% of First Trust Advisors's portfolio in Q1 2026, its #1226 holding.
First Trust Advisors first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 11 quarters since.
First Trust Advisors's Adaptive Biotechnologies position peaked at $27.9M in Q4 2020.
295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.